case_images: PMC10361752_01
case_images: (i) pericarbon MORE surgical bioprosthetic valve (ii) hancock II surgical bioprosthetic valve.
case_images: fcvm-10-1152280-g001.jpg
case_images: PMC10361752_05_fcvm-10-1152280-g001.jpg
case_images: F1
case_images: Almost 17 years later, the patient developed symptomatic mitral stenosis and tricuspid regurgitation requiring surgical replacement of both valves {mechanical prosthesis Carbomedics 27 mm in mitral position and Pericarbon More 29 mm in tricuspid position [Figure 1(ii)].
case_images: Represents fluoroscopic imaging after VIV implantation of all 5 patients (case 1 to case 5).
case_images: fcvm-10-1152280-g002.jpg
case_images: PMC10361752_05_fcvm-10-1152280-g002.jpg
case_images: F2
case_images: Sciences Pvt. Ltd., India), the BE Myval THV was successfully implanted, without pacing (Table 1, Figures 2: 5A,B) but three hours after the procedure, due to moderate femoral vein bleeding, two units of packed red blood cells were transfused, and surgical intervention was needed to manage this complication. Seven days after the procedure, the patient was discharged on anticoagulant therapy (VKA) (Table 2).
case_images: PMC10361752_02
case_images: (i) pericarbon MORE surgical bioprosthetic valve (ii) hancock II surgical bioprosthetic valve.
case_images: fcvm-10-1152280-g001.jpg
case_images: PMC10361752_05_fcvm-10-1152280-g001.jpg
case_images: F1
case_images: Almost 17 years later, the patient developed symptomatic mitral stenosis and tricuspid regurgitation requiring surgical replacement of both valves {mechanical prosthesis Carbomedics 27 mm in mitral position and Pericarbon More 29 mm in tricuspid position [Figure 1(ii)].
case_images: Represents fluoroscopic imaging after VIV implantation of all 5 patients (case 1 to case 5).
case_images: fcvm-10-1152280-g002.jpg
case_images: PMC10361752_05_fcvm-10-1152280-g002.jpg
case_images: F2
case_images: Sciences Pvt. Ltd., India), the BE Myval THV was successfully implanted, without pacing (Table 1, Figures 2: 5A,B) but three hours after the procedure, due to moderate femoral vein bleeding, two units of packed red blood cells were transfused, and surgical intervention was needed to manage this complication. Seven days after the procedure, the patient was discharged on anticoagulant therapy (VKA) (Table 2).
case_images: PMC10361752_03
case_images: (i) pericarbon MORE surgical bioprosthetic valve (ii) hancock II surgical bioprosthetic valve.
case_images: fcvm-10-1152280-g001.jpg
case_images: PMC10361752_05_fcvm-10-1152280-g001.jpg
case_images: F1
case_images: Almost 17 years later, the patient developed symptomatic mitral stenosis and tricuspid regurgitation requiring surgical replacement of both valves {mechanical prosthesis Carbomedics 27 mm in mitral position and Pericarbon More 29 mm in tricuspid position [Figure 1(ii)].
case_images: Represents fluoroscopic imaging after VIV implantation of all 5 patients (case 1 to case 5).
case_images: fcvm-10-1152280-g002.jpg
case_images: PMC10361752_05_fcvm-10-1152280-g002.jpg
case_images: F2
case_images: Sciences Pvt. Ltd., India), the BE Myval THV was successfully implanted, without pacing (Table 1, Figures 2: 5A,B) but three hours after the procedure, due to moderate femoral vein bleeding, two units of packed red blood cells were transfused, and surgical intervention was needed to manage this complication. Seven days after the procedure, the patient was discharged on anticoagulant therapy (VKA) (Table 2).
case_images: PMC10361752_04
case_images: (i) pericarbon MORE surgical bioprosthetic valve (ii) hancock II surgical bioprosthetic valve.
case_images: fcvm-10-1152280-g001.jpg
case_images: PMC10361752_05_fcvm-10-1152280-g001.jpg
case_images: F1
case_images: Almost 17 years later, the patient developed symptomatic mitral stenosis and tricuspid regurgitation requiring surgical replacement of both valves {mechanical prosthesis Carbomedics 27 mm in mitral position and Pericarbon More 29 mm in tricuspid position [Figure 1(ii)].
case_images: Represents fluoroscopic imaging after VIV implantation of all 5 patients (case 1 to case 5).
case_images: fcvm-10-1152280-g002.jpg
case_images: PMC10361752_05_fcvm-10-1152280-g002.jpg
case_images: F2
case_images: Sciences Pvt. Ltd., India), the BE Myval THV was successfully implanted, without pacing (Table 1, Figures 2: 5A,B) but three hours after the procedure, due to moderate femoral vein bleeding, two units of packed red blood cells were transfused, and surgical intervention was needed to manage this complication. Seven days after the procedure, the patient was discharged on anticoagulant therapy (VKA) (Table 2).
case_images: PMC10361752_05
case_images: (i) pericarbon MORE surgical bioprosthetic valve (ii) hancock II surgical bioprosthetic valve.
case_images: fcvm-10-1152280-g001.jpg
case_images: PMC10361752_05_fcvm-10-1152280-g001.jpg
case_images: F1
case_images: Almost 17 years later, the patient developed symptomatic mitral stenosis and tricuspid regurgitation requiring surgical replacement of both valves {mechanical prosthesis Carbomedics 27 mm in mitral position and Pericarbon More 29 mm in tricuspid position [Figure 1(ii)].
case_images: Represents fluoroscopic imaging after VIV implantation of all 5 patients (case 1 to case 5).
case_images: fcvm-10-1152280-g002.jpg
case_images: PMC10361752_05_fcvm-10-1152280-g002.jpg
case_images: F2
case_images: Sciences Pvt. Ltd., India), the BE Myval THV was successfully implanted, without pacing (Table 1, Figures 2: 5A,B) but three hours after the procedure, due to moderate femoral vein bleeding, two units of packed red blood cells were transfused, and surgical intervention was needed to manage this complication. Seven days after the procedure, the patient was discharged on anticoagulant therapy (VKA) (Table 2).